TASIGNA caps 150 mg 112 pce
7680580070049
CH-58007
L01EA03
07.16.1.
Reimbursement limitations:
TASIGNA
Traitement des patients avec une leucémie myéloïde chronique à chromosome philadelphia positif (Ph+ CML) en …
1 / 3
google
Details
- Product number
- 5800702
- CPT
- -
- Packaging group
- 112
- Unit
- Kapsel(n)
- Composition
- nilotinibum 150 mg ut nilotinibi hydrochloridum monohydricum, lactosum monohydricum 117.08 mg, crospovidonum, poloxamerum 188, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (rubrum), E 172 (flavum), Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammoniae solutio 28 per centum, pro capsula.
Articles (1)
Tasigna 150 mg, Kapseln
Kapseln
112
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
150.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
117.08 MG | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1999.75
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/10/2010
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 58007
- Drug name
- Tasigna, Kapseln
- Galenic form
- KAHA
- ATC Code
- L01EA03
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 24/07/2007
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TASIGNA caps 150 mg 112 pce
- Description (DE)
- TASIGNA Kaps 150 mg 112 Stk
- Market launch
- 24/08/2010
- Narcotic (BTM)
- No